Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study
Journal of Thoracic Disease · 2024-07 · 16 (7) · 4340-4349
DOI: 10.21037/jtd-24-270 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Thoracic Disease, 2024-07. Verfasst von Adam Austin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Interstitial lung diseases (ILDs) are a group of pulmonary disorders affecting the lung's structure. Acute exacerbation of ILD (AE-ILD) following medical procedures is a significant clinical concern. Lung cryoprobe transbronchial biopsy (cryobiopsy) is a relatively new diagnostic technique for ILD, but data on AE-ILD post-cryobiopsy is limited. This study aims to fill this gap by examining the prevalence, risk factors, and outcomes of AE-ILD following cryobiopsy.
Methods
This multicenter retrospective study analyzed data from patients who underwent cryobiopsy for ILD diagnosis at three U.S. institutions between January 2014 and August 2022. The study included patients over 18 years with confirmed or suspected ILD, categorized into those who experienced AE-ILD post-cryobiopsy and those who did not.
Results
Out of 111 patients, 3.6% experienced AE-ILD, with a 50% mortality rate in these cases. The study cohort was predominantly white, with a median age of 69.0 years. Common comorbidities included tobacco use and hypertension. Patients who developed AE-ILD had an increased median number of biopsies. The overall 30-day mortality was 1.8%. Overall complication rate was 32%, including pneumonia, pneumothorax, AE-ILD, and bleeding requiring intervention. The study findings suggest that bronchoscopic cryobiopsy may be associated with lower overall mortality, particularly in patients with compromised lung function.
Conclusions
This study provides significant insights into AE-ILD following cryobiopsy, underscoring the need for careful patient selection and procedural assessment. While cryobiopsy may offer a safer alternative to surgical lung biopsy in specific patient cohorts, the elevated risk of AE-ILD necessitates further research to optimize patient outcomes and procedural safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USA.
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Toledo Medical Center, Toledo, OH, USA.
- Division of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA.
ORCID-Profile: Hiren J Mehta
Zitieren
APA
Austin, A., Jaber, J., Fu, K., Zeineddine, L., Omballi, M., Mckenney, G., Abdelghani, R., Espinoza, D., Becnel, D., & Mehta, H. J. (2024). Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study. Journal of Thoracic Disease, 16(7), 4340-4349. https://doi.org/10.21037/jtd-24-270
Vancouver
Austin A, Jaber J, Fu K, Zeineddine L, Omballi M, Mckenney G, et al. Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study. Journal of Thoracic Disease. 2024;16(7):4340-4349. doi:10.21037/jtd-24-270
BibTeX
@article{Austin2024,
author = {Austin, Adam and Jaber, Johnny and Fu, Katherine and Zeineddine, Lauran and Omballi, Mohamed and Mckenney, George and Abdelghani, Ramsy and Espinoza, Diana and Becnel, David and Mehta, Hiren J},
title = {Acute exacerbation of interstitial lung diseases and mortality post-cryobiopsy: a multicenter cohort study},
journal = {Journal of Thoracic Disease},
year = {2024},
volume = {16},
number = {7},
pages = {4340--4349},
doi = {10.21037/jtd-24-270}
}
EUVIMED